Skip to main content

Dr. Muhammad Raza, M.D

Hematology & Oncology (Hematology & Oncology Physician)

  • Medicare participating

At a glance

Years since graduation
26
In the NPI registry since
2007
Medicare patients seen, 2024
423

The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is

Education and training

  • 2007Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier

Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).

Specialties and state licenses

  • Hematology & Oncology Physician primary
    TN license 47036 · AR license E8094 · MS license 21773

As reported to the NPI registry. To confirm a license is current, check the state medical board.

Map: Hematology & Oncology per capita by county →

Where they work

Hospitals

Medical groups

Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.

Medicare patients and services

Medicare patients, 2024
423
Services billed
2,714
Patients’ average age
74
Most frequent Medicare services, 2023
ServiceTimesPatients
Established patient office or other outpatient visit, 30-39 minutes693211
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes513102
Established patient office or other outpatient visit, 20-29 minutes134109
Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes8170
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes5132
Established patient office or other outpatient visit, 40-54 minutes4837
New patient office or other outpatient visit, 45-59 minutes2525
Biopsy and aspiration of bone marrow sample for diagnosis2221
Hospital discharge day management, more than 30 minutes1918
New patient office or other outpatient visit, 60-74 minutes1212

Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.

Medicare prescriptions

Most prescribed drugs, Medicare Part D 2024
DrugPrescriptions
Acyclovir
Other prescribers in Memphis, TN
196
Eliquis (apixaban)
Other prescribers in Memphis, TN
132
Pantoprazole Sodium
Other prescribers in Memphis, TN
100
Oxycodone-Acetaminophen (oxycodone hcl/acetaminophen)
Other prescribers in Memphis, TN
85
Calquence (acalabrutinib maleate)76
Revlimid (lenalidomide)75
Ondansetron Hcl
Other prescribers in Memphis, TN
68
Prednisone
Other prescribers in Memphis, TN
66
Pomalyst (pomalidomide)65
Ondansetron Odt (ondansetron)
Other prescribers in Memphis, TN
57

Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.

Payments from drug and device companies

In 2025, 34 companies reported 104 payments worth $11,762 in total to this clinician.

By company
Kite Pharma, Inc.$9,662
Janssen Biotech, Inc.$346
AbbVie Inc.$198
Pfizer Inc.$157
Daiichi Sankyo Inc.$154
E.r. Squibb & Sons, L.l.c.$139
Celgene Corporation$109
Tempus Ai, Inc$108
By type
Consulting Fee$8,330
Food and Beverage$2,426
Travel and Lodging$962
Education$43.25

What the payments were for

Largest payments other than meals
DateCompanyWhat it was forAmount
May 4, 2025Kite Pharma, Inc.
May 4, 2025
Consulting Fee
Yescarta · CELLT
Company’s description;4099421;GTF;11322515
$8,330
May 2, 2025Kite Pharma, Inc.
May 2, 2025
Travel and Lodging
Yescarta · CELLT · travel to Tyson Corner, VA · in-kind
Company’s description;4099331;GTF;11322515
$535
May 2, 2025Kite Pharma, Inc.
May 2, 2025
Travel and Lodging
Yescarta · CELLT · travel to Tyson Corner, VA · in-kind
Company’s description;4099352;GTF;11322515
$427
Nov 19, 2025AstraZeneca Pharmaceuticals LP
Nov 19, 2025
Education
ENHERTU · Oncology · in-kind
Company’s descriptionJournal Article
$43.25

Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.

From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.

Who received the most in Tennessee →

Other Hematology & Oncology clinicians in Memphis

Sources

NPI registry (CMS NPPES, November 2026; record last updated June 22, 2021), Medicare Care Compare, Medicare Physician & Other Practitioners (2024), Medicare Part D Prescribers (2024) and Open Payments (2025). Information is self-reported or billed data and may be out of date; call before visiting.

NPI 1619198512. Official NPI registry record (opens in a new tab). Clinicians can correct their information in NPPES; changes appear here after our next monthly update.